-
Ponatinib combined with steroid first-line therapy is promising in elderly and unfit patients with Ph+ acute lymphoblastic leukemia
Time of Update: 2022-06-14
Studies have shown that imatinib combined with steroid induction therapy, followed by imatinib combined with chemotherapy and stem cell transplantation (SCT), can achieve an overall survival (OS) rate of 49% and 5-year disease-free survival in adult patients with Ph+ ALL.
-
AJPMR: A comparative study of extracorporeal shock wave therapy and steroid therapy for coccygeal pain
Time of Update: 2022-05-23
Within-group analysis of VAS in ESWT and steroid injection recipientsThis study revealed the benefits of shockwaves in improving pain and function during follow-up .
-
BASF's first-quarter sales reached 23.1 billion euros, up 19% year-on-year
Time of Update: 2022-05-19
EBIT before special items also increased significantly in the Industrial Solutions, Materials and Nutrition & Care business areas .
-
DSM sells protective materials business for more than 1.4 billion euros
Time of Update: 2022-05-18
44 billion euros (about 10.
33 billion euros in cash .
-
Indomethacin, meloxicam, celecoxib... What should I pay attention to when choosing non-steroidal
Time of Update: 2022-05-15
-steroidal anti-inflammatory drugs can produce some adverse reactions while using them for a long time . The adverse reactions of non-steroidal anti-inflammatory drugs are mainly manifested
-
Portuguese Port and Douro wine sales in 2021 reach record 600 million euros
Time of Update: 2022-05-15
> of Portuguese Port and Douro wines in 2021 will reach 600 million euros, a record high; The total export value also reached 403 million euros, a year-on-year increase of 12. 4%, of which Port wine exports exceeded 330 million
-
WACKER sales top 2 billion euros for the first time in the first quarter of 2022, EBITDA more than doubles from the previous year
Time of Update: 2022-05-09
>. >Driven by the above factors, the Group's EBIT also increased significantly, achieving EUR 550 million during the reporting period, more than three times that of the same period last year (EUR 166 million
-
IBD: Histological inflammatory activity and history of steroid use are risk factors for clinical recurrence in patients with ulcerative colitis
Time of Update: 2022-05-08
This study confirmed that in UC patients with MES of 0 or 1, histological inflammatory activity and history of steroid use were risk factors for clinical recurrence in UC patients .
-
Express Advances Innovative Treatments for Multiple Myeloma, Sanofi and Blackstone Reach 300 Million Euro Partnership
Time of Update: 2022-04-30
formulations of Sarclisa, Sanofi has partnered with Enable Injections, an innovator in drug delivery technology, to advance the development of subcutaneous delivery of Sarclisa with the goal of providing a unique patient-centered therapeutic experience
-
Bayer sells pest control business for 2.4 billion euros
Time of Update: 2022-04-24
Bayer's Pest Control business provides environmental solutions for the control of pests and weeds in non-agricultural sectors such as vector control, professional pest management, vegetation management, forestry, turf and ornamental plants .
-
EU agricultural trade to reach 347 billion euros in 2021
Time of Update: 2022-04-19
1 billion euros) is the EU's largest trading partner, accounting for 21% of exports outside the EU, followed by the United States (12%, 24.
-
BASF's sales in 2021 will be 78.6 billion euros, up 33% year-on-year
Time of Update: 2022-04-17
6 billion euros, an increase of 33 percent over the previous year .
-
more than 500 million euros to enhance technical capabilities
Time of Update: 2022-04-16
for the entire mRNA industry chain> > > Darmstadt, Germany, February 23, 2022 – Merck, the world’s leading technology company, announced today that it has completed a transaction of approximately $780
-
The drug market exceeds 400 million euros, and the original research manufacturers will usher in challengers
Time of Update: 2022-04-15
Today, almost every product market has been firmly controlled by giants in this field, such as Hengrui, Yangzijiang, Bracco, GE, Bayer, and Beilu Pharmaceuticals, all of which have been deeply involved in the contrast agent market for many years .
-
The market size of the inspection and testing industry in 2025 may exceed 250 billion euros
Time of Update: 2022-04-01
From the perspective of the market size of the inspection and testing industry, the industry has maintained a good growth momentum, with the market size exceeding 200 billion euros.
-
455 million euros!
Time of Update: 2022-03-04
The transaction will significantly enhance EuroChem's nitrogen business in Europe, adding production assets in Austria, Germany and France, and increasing use of the Danube's comprehensive sales and distribution network .
-
There is a new method for the synthesis of non-steroidal anti-inflammatory drug precursors
Time of Update: 2022-03-02
With the discovery and application of asymmetric catalytic synthesis methods, the preparation of α-arylpropionic acids has become more efficient, convenient and green and economical, which greatly promotes the development of non-steroidal anti-inflammatory drugs .
-
Engie will invest 800 million euros in green gas
Time of Update: 2022-02-19
According to reports, the French energy company Engie plans to invest 800 million euros (900.
-
Air Liquide invests 50 million euros in new air separation plant in Russia
Time of Update: 2022-02-18
Air Liquide will invest approximately 50 million euros to build the most advanced air separation equipment (ASU), which will improve the energy efficiency and overall environmental footprint of the Severstal production process .
-
Indomethacin, meloxicam, celecoxib... how to choose non-steroidal anti-inflammatory drugs for AS
Time of Update: 2022-01-21
What are the side effects of NSAIDs?Like any other drug, non-steroidal anti-inflammatory drugs can produce some adverse reactions when used for a long time .
